Therapy News and Research

RSS

Perfluorocarbon nanoparticles track living cells

Stem cell therapy, primarily bone marrow transplantation, plays a key role in treating leukemia and other types of cancer.

26 Feb 2007

Genetically caused deafness may be reversible by compensating for a missing protein

Emory University researchers have found that in mice, increasing the amount of the protein connexin26 in the ear's cochlea compensates for an absence of another protein, connexin30.

26 Feb 2007

Androgen deprivation therapy may increase risk of death from heart disease in older men

Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.

26 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

26 Feb 2007

Osteopenia and cancer in children and adolescents

Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.

26 Feb 2007

Hormone patch could be safer than pills in relieving the symptoms of the menopause

According to new research by French scientists hormone skin patches and gels are far less likely than pills to cause dangerous blood clots.

26 Feb 2007

Call for herpes simplex virus control measures for prevention of HIV transmission

Experts call for HSV control measures, including vaccine, to rank high on international HIV prevention and research agenda as exciting trial findings are published.

22 Feb 2007

Alternative, diet-based method of treating brain cancer

The biologists found that KetoCal, a commercially available high-fat, low-carbohydrate diet designed to treat epilepsy in children, can significantly decrease the growth of brain tumors in laboratory mice.

22 Feb 2007

Clarient receives patent for "automated detection of objects in a biological sample"

Clarient, Inc. has announced that it has been granted a new U.S. patent related to the detection and quantification of rare tumor cells in blood and bone marrow.

21 Feb 2007

Woman awarded millions in Prempro HRT breast cancer trial

A woman in the United States has been awarded damages to the tune of $3 million after taking drug manufacturer Wyeth to court over it's postmenopausal hormone replacement therapy Prempro.

21 Feb 2007

Spearmint tea - natural treatment for hirsutism

Turkish researchers say women who suffer from excessive hair growth (hirsutism) may be helped by drinking spearmint tea.

21 Feb 2007

Health care professionals should focus on women's lifetime heart disease risk

The 2007 Guidelines for Preventing Cardiovascular Disease in Women -- published today in a special women's health issue of Circulation: Journal of the American Heart Association -- also include new directions for using aspirin, hormone therapy and vitamin and mineral supplements in heart disease and stroke prevention in women.

20 Feb 2007

New test identifies suitable lymphoma patients likely to respond to new therapy

Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.

20 Feb 2007

Hormone prolactin key to repairing nerve cell damage

The mystery of why multiple sclerosis (MS) tends to go into remission while women are pregnant may be the secret to overcoming the devastating neurodegenerative disease, according to University of Calgary researchers who have shown that a pregnancy-related hormone is responsible for rebuilding the protective coating around nerve cells.

20 Feb 2007

Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma

Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.

20 Feb 2007

Chemotherapy drug bortezomib packs a one-two punch

Cancer can be wily, and those who treat the disease have amassed a wide array of weapons with which to fight it and kill tumors.

20 Feb 2007

Transmission of drug-resistant tuberculosis among treated patients in Shanghai

A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance.

20 Feb 2007

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.

20 Feb 2007

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

A promising approach to gene therapy involves short DNA fragments (interfering RNA) that bind to specific genes and block their "translation" into the corresponding, disease-related protein.

20 Feb 2007

Nanoparticles advance photodynamic therapy to kill tumor cells

Photodynamic therapy (PDT) is a powerful approach for destroying tumors, one that uses light and a light-sensitive chemical to rapidly kill cells.

20 Feb 2007

Therapy News and Research

Perfluorocarbon nanoparticles track living cells

Genetically caused deafness may be reversible by compensating for a missing protein

Androgen deprivation therapy may increase risk of death from heart disease in older men

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Osteopenia and cancer in children and adolescents

Hormone patch could be safer than pills in relieving the symptoms of the menopause

Call for herpes simplex virus control measures for prevention of HIV transmission

Alternative, diet-based method of treating brain cancer

Clarient receives patent for "automated detection of objects in a biological sample"

Woman awarded millions in Prempro HRT breast cancer trial

Spearmint tea - natural treatment for hirsutism

Health care professionals should focus on women's lifetime heart disease risk

New test identifies suitable lymphoma patients likely to respond to new therapy

Hormone prolactin key to repairing nerve cell damage

Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma

Chemotherapy drug bortezomib packs a one-two punch

Transmission of drug-resistant tuberculosis among treated patients in Shanghai

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

Nanoparticles advance photodynamic therapy to kill tumor cells

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News